Health & Fitness
Health and Fitness
Health and Fitness 
Thu, February 3, 2011
Wed, February 2, 2011
Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
Sun, January 9, 2011
Fri, January 7, 2011
Genoptix, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Novartis
DALLAS--([ BUSINESS WIRE ])--[ The Briscoe Law Firm, PLLC ], founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the securities litigation law firm of [ Powers Taylor LLP ] are investigating potential legal claims against the Board of Directors of Genoptix, Inc. (aGenoptixa or aGXDXa) (NASDAQ: GXDX) related to the proposed buyout of Genoptix, Inc. by Novartis. The investigation relates to the fairness of the proposed transaction to Genoptix, Inc.a�s shareholders, possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Genoptix for approving this transaction, and whether the companya�s Board of Directors acted in the shareholdersa� best interests.
"Based on the lack of an appreciable premium to shareholders, and other factors, we have concern whether the proposed acquisition is fair to Genoptix shareholders, and we want to ensure that the shareholders are receiving the maximum value for their stock"
The definitive merger agreement involves a cash transaction valued at approximately $470 million. Under the proposed transaction, Genoptix shareholders will receive a cash payment of $25.00 for each share of GXDX common stock they hold. However, independent analysts have placed the stocka�s value as high as $28.00 per share. aBased on the lack of an appreciable premium to shareholders, and other factors, we have concern whether the proposed acquisition is fair to Genoptix shareholders, and we want to ensure that the shareholders are receiving the maximum value for their stock,a said shareholder rights attorney Willie Briscoe.
If you currently own shares of Genoptix/GXDX and would like additional information regarding this investigation, or if you have information regarding the allegations involved in this transaction, please contact Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877) 397-5991, or via email at [ WBriscoe@TheBriscoeLawFirm.com ]. There is no cost or fee to you.
The Briscoe Law Firm is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation matters.
Powers Taylor LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.
